PDF
Citation
Print
Introduction
Cell therapy is a new advanced method for the treatment of many diseases. Both stem cells and differentiated cells seem appropriate candidates for cell therapy. Mesenchymal stem cells (MSCs) are a well-known candidate for cell therapy for several reasons, including ease of in vitro expansion, lack of immune response, and appropriateness for delivery of special proteins to the target tissue [1-3].
MSCs in adipose tissues, which are also called adipose-derived stem cells (ASCs), are similar to bone marrow stem cells (BMSCs) [4, 5]. ASCs features are highly similar to those of MSCs in terms of morphology, division rate, and pluripotent capacity [6, 7]. Moreover, ASCs have several advantages over BMSCs, such as a higher ratio of isolation from adipose tissue which is almost 40 folds higher than that of BMSCs [8-10], possibility of autologous transplantation of ASCs to reduce the immune response and ethical problems regarding stem cell application [11], and easier isolation and in vitro expansion of ASCs [12]. Therefore, ASCs seem more appropriate and promising for effective cell therapy.
Deprenyl (Dep), an inhibitor of monoamine oxidase B (MAO-B) [13], has been used to treat Parkinson’s disease (PD) since the 1970s [14]. Dep is highly absorbed by the digestive system and passes through the blood-brain-barrier via the circulatory blood system and quickly penetrates the brain and spinal cord and inhibits the MAO-B [15], which in turn, causes the inhibition of dopamine catabolism, alleviating the PD symptoms. Dep is also known as an anti-depressive [16], anti-apoptotic [17, 18], and anti-ageing medicine [19, 20]. Furthermore, Dep-induced neural-like morphology occurs by the induction of neurotrophic factor gene expression. Neurotrophins (NTFs) are a group of small proteins necessary for the growth, survival, and differentiation of neurons both in the central nervous system and peripheral nervous system [21-23]. NTFs are also able to repair damaged neurons in vitro [24, 25].
NTFs are classified into three main groups: 1) neurotrophin family, including the three subgroups of nerve growth factor (NGF) which promote myelination and differentiation of neurons [26, 27], neurotrophin-3 (NTF-3) which is necessary for neuronal survival [28], and brain-derived neurotrophic factor (BDNF) essential for neuron survival [29], 2) the ciliary neurotrophic factor (CNTF family), and 3) glial cell line-derived neurotrophic factor (GDNF) family [30]. Dep can induce neuronal morphology in embryonic stem cells (ESCs) [31]. It also induces the expression of adult neural markers, such as BDNF and NTF-3 in BMSCs [26].
Dep efficiently induced the expression of BDNF, NTF-3, and NGF in more than 82.5% of treated BMSCs [32]. It has been reported that the induction of neuron-like morphology in treated embryonic carcinoma stem cells by Dep takes place in a dose-dependent manner [33]. The expression of NGF, BDNF and GDNF factors were induced by Dep in cultured mouse astrocytes [32, 34, 35]. With this background in mind, we sought to study the effect of Dep on human adipose-derived stem cells (hASCs) in vitro to investigate the possibility of neurotrophic factor genes induction in hASCs and their differentiation into neuron-like cells for further cell therapy of neurodegenerative diseases.
Materials and Methods
Human adipose-derived stem cells isolation
To isolate hASCs, adipose tissue samples were collected from female patients undergoing liposuction (mean age 40±5 years, Velayat Hospital, Damghan, Iran) (IR.SBMU.RIGLD. REC. 1395. 207). Informed consent was obtained from the participants and approval of the local Ethics Committee at Velayat Hospital (Damghan, Iran). The study was carried out following the guidelines of the Medical Ethics Committee, Ministry of Health of Iran.
Firstly, the samples were cut into very small pieces, and then 0.2% collagenase (Gibco, 17100-017; Sigma-Aldrich, St.Louis, MO, USA) was added, and the solution was incubated at 37°C for 2 hours. To stop digestion, DMEM (Gibco, Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS) was added to the suspension and centrifuged at 1,200 rpm for 5 minutes at 37°C. Finally, the isolated cells were transferred and cultured in a 25 cm2 flask and incubated at 37°C in 5% CO2 for 72 hours. hASCs adhered to the bottom of the flask, while floating blood cells were washed away by changing the medium with a fresh one. Cells were passaged at about 70%–80% of confluency. Experimental groups were as follows: medium, cultured P4-cells in FBS free medium (Dulbecco’s modified minimum essential medium); Medium+FBS, cultured P4-cells in medium containing 10% FBS; Dep10–7+FBS, cultured P4-cells in medium+10% FBS containing 10–7 M Dep; and Dep 10–6–Dep 10–10, cultured cells in FBS free medium containing 10–6–10–10 M Dep.
Flow cytometry analysis
Passage 4 of the hASCs was trypsinized and then centrifuged at 2000 rpm for 3 minutes at room temperature, resuspended in FACS (phosphate-buffered saline [PBS], 2% FBS) and incubated on ice for 10 minutes. Then, fluorescence antibodies against CD73-PE (BD Biosciences, San Jose, CA, USA), CD44-FITC (Immunostep), CD105-PE (Exbio/Czech), CD90-FITC (Exbio), CD45-FITC (BD Biosciences), and CD34-PE (Exbio) were added and incubated at 4°C for 30 minutes. After removing the non-conjugated antibodies by three washes, the cells were resuspended in PBS and subjected to flow cytometry (BD FACS Calibur; BD Biosciences).
Cell viability
In each group, cultured hASCs were stained by trypan blue and counted with a hemocytometer five times. Suspension of the P4 of hADSCs was trypsinized, and trypan blue was added (10 µl/10 µl) and loaded on a hemocytometer with a pipette tip. Trypan blue penetrates the membranes of dead cells, coloring them blue, it is not absorbed by membranes of live cells, excluding live cells from staining. To perform the count, magnification was ×400, and cell concentration was calculated using the following formula:
Live cells/ml= live cells counted×dilution factor (2)×104/4 squares
hASCs induction to osteoblasts
Induction was performed according to the references [36, 37]. Isolated hASCs of P4 were cultured in 12-well plates, and the medium was replaced with osteogenesis differentiation medium (StemPro Osteogenesis Differentiation Kit, A10072-01; Invitrogen). About 21 days later, the cells were stained with the Alizarin Red method. Briefly, cells were fixed in 4% formaldehyde for 1 hour at 4°C and then incubated with Alizarin Red for 2 minutes. Then, cells were washed with PBS and observed by an inverted microscope (E600-Eclipse Nikon; Nikon, Tokyo, Japan) equipped with a digital camera (DXM 1200 Camera Nikon Digital, Nikon).
hASCs induction to adipocytes
Based on the protocols [36, 37], the isolated hASCs of P4 were subcultured in 12-well plates containing adipogenesis differentiation medium (StemPro Adipogenesis Differentiation Kit, A10070-01; Invitrogen). After 21 days, the cells were fixed and stained with the Oil Red-O method. Briefly, cells were washed with PBS twice and then fixed in 4% formaldehyde for 1 hour at 4°C. Then, the cells were washed with 70% ethanol for 10–15 minutes and then stained with Oil Red. Finally, cells were washed with 70% ethanol about three times, and microscopic observation was performed to check the results.
Tyrosine hydroxylase immunostaining
Treated cells were cultured on gelatinized coverslips and fixed in 4% paraformaldehyde for 20 minutes at 4ºC. They were then permeabilized in 0.1% Triton X-100 for 15 minutes and blocked in 10% normal goat serum for 15 minutes. The cells were incubated with primary antibody (Rabbit anti-tyrosine hydroxylase [TH], AB152, Chemicon, China) overnight at 4ºC. After washing in 0.01 M PBS, the cells were incubated with a secondary antibody (FITC-conjugated anti-rabbit) at 37ºC for 30 minutes. Immunopositive cells were examined using a fluorescent microscope (E600-Eclipse Nikon) equipped with a digital camera (DXM 1200 Camera Nikon Digital).
MTT assay for doubling time evaluation
MTT assay kit was purchased from Sigma (St. Louis, MO, USA) and used according to the standard protocol. The P4-cells were seeded at the density of 2×104 cells/well in sterile 96-well plates containing 200 µl of DMEM+10% FBS. Cell division was evaluated in the presence of various concentrations of Dep (purchased from Zahravi Pharmaceutical Co., Tabriz, Iran) ranging from 10–6 to 10–10 M for 24 and 48 hours. Then, the supernatant was discarded and replaced with 100 µl fresh medium plus 10 µl MTT solution (5 mg/ml; Sigma), and cells were incubated at 37°C for 4 hours. Finally, 85 µl of the medium was replaced with 50 µl of DMSO and incubated for more than 10 minutes. Optical density was measured by an ELISA reader (Biotek, Winooski, VT, USA) at 540 nm. The experiment was repeated five times for each group.
RT-PCR for neurotrophic factor genes expression
Reverse transcription polymerase chain reaction (RT-PCR) was performed to evaluate the expression of GDNF, BDNF, NGF, NTF-3, and NTF-4 genes. Briefly, after treatment of hASCs with different concentrations of Dep from 10–6 to 10–8 M for 24 hours, total RNA extraction and cDNA synthesis were carried out. Then, synthetic cDNA was used for PCR. The primer sequences for each of the above factors are listed in Table 1. PCR products were evaluated in 1.5% agarose gel and finally, the intensity of gene bands was checked by the Image J software (National Institute of Mental Health, Bethesda, MD, USA).
Results
Flow cytometry of hASCs
The identity of isolated hASCs was confirmed by the evaluation of surface markers expression. As the results showed, about 98% of the cells expressed all surface markers (i.e., CD73, CD44, and CD105), except for CD90 that was expressed in approximately 99.6% of the isolated cells. Moreover, more than 97% of the cells did not express CD34 and CD45 surface markers (Fig. 1). The separated hASCs by flow cytometry revealed the normal morphology of MSCs in culture conditions (Fig. 2A, B).
Induction of hASCs into osteoblasts and adipocytes
The pluripotency of the isolated hASCs was evaluated by the differentiation of cells into osteoblasts and adipocytes. The fourth passage of hASCs was cultured in a specified medium for three weeks. Adipogenic differentiation was confirmed by the formation of small lipid droplets formed during the first week of treatment and stained with Oil Red (Fig. 2C, D). Osteogenic differentiation was confirmed by the production of calcium phosphate and mineralized extracellular matrix in induced cells, which were stained with Alizarin Red (Fig. 2E, F).
hASCs proliferation rate at different concentrations of deprenyl
Cell survival rate at different concentrations of Dep (from 10–6 to 10–10 M) for 24 and 48 hours was measured by the hemocytometer method. Exposure to 10–7 M of Dep for 24 hours caused a significant increase in viable cells compared with a similar concentration of incubated cells for 48 hours (Fig. 3). Treated cells for 48 hours showed a decline in cell viability by increasing the concentration of Dep (Fig. 3). Therefore, Dep at a concentration of 10–7 M for 24 hours incubation was selected as the effective dosage and incubation time. There was no significant difference between the treated cells with 10–7 M Dep incubated for 24 hours in the absence and presence of serum (Fig. 3). Results of the dose-response studies of Dep showed an inverted U-shaped relationship between different doses of Dep and optical density. Dep at the concentrations of 10–6 to10–8 M showed a significant increase in absorption compared to the Medium group, with the peak of optical density in 10–7 M Dep.
In addition, co-treatment with 10–7 M Dep and FBS (Dep 10–7+FBS group) showed a significant increase in optical density compared to the Medium group. As there was no significant difference between the “Dep 10–7+FBS” and “Dep 10–7” groups, the proliferative role of Dep was corroborated.
Among all the treatments, the highest increase in optical density was observed in the “Medium+FBS” group. Comparing the “Medium+FBS” and “Dep10–7+FBS” groups with the “Medium” group, we found that Dep had a high proliferation ability.
Evaluation of dividing rate of treated hASCs with different concentrations of deprenyl
hASCs division rate (population doubling time) was evaluated by the MTT assay. hASCs were treated with different concentrations of Dep ranging from 10–10 to 10–6 M for 24 hours, and then optical density (540 nm) was measured. Division rate of induced cells with 10–7 M Dep in serum-free medium was significantly increased as compared to the other doses and medium groups. The division rate in the presence and absence of serum for 10–7 M of Dep was almost identical (Fig. 4). Pretreatment with 10–7 M of Dep caused a significant decrease in the division rate compared to the Medium+FBS group.
Induction of hASCs to neuron
Based on Dep toxicity and MTT assay, 10–7 M of Dep for 24 hours exhibited optimal results for survival and proliferation rates of hASCs. Therefore, hASCs were treated with various concentrations of Dep spanning from 10–6 to 10–8 M for 24 hours in the absence of serum. The Dep-induced TH-positive cells in the form of neuron-like cells are shown in Fig. 5A, B. To evaluate the neurotrophin genes expression, RT-PCR was used, and the PCR products were put in 1.5% agarose gel (Fig. 5C). The intensity of PCR bands for each gene was measured using the Image J software.
The graph obtained from the Image J software indicated a significant increase in BDNF and NTF-3 genes expression in Dep-induced cells, in comparison with cultured cells in the medium (Fig. 6). However, no significant difference was seen among various Dep concentrations (10–6–10–8 M).
The expression of NTF-4 gene was significantly increased in 10–8 M Dep-treated cells as compared to the 10–7 and 10–6 M Dep-treated cells. Dep did not have any effect on NGF gene expression, and finally, there was no significant difference in GDNF gene expression among Dep-treated cells. On the other hand, at all Dep concentrations, GDNF gene expression was almost similar to that in the control group.
Discussion
MSCs are the most appropriate candidates for cell therapy. So far, BMSCs have been the subject of many studies for cell therapy. However, BMSCs have several drawbacks limiting their application, including quick in vitro senescence and the risk of tumorigenesis. hASCs are a kind of MSCs that represent all MSCs’ features [36, 37]. Although replacement of BMSCs with hASCs eliminate nearly all BMSCs disadvantages, the risk of tumorigenesis has remained unresolved so far [8, 10]. To resolve this issue, differentiated cells resulted from induced stem cells seem a better candidate than undifferentiated stem cells. In this study, we investigated neurotrophic factor genes expression after the induction of hASCs by Dep and the possibility of hASCs differentiation into neuron-like cells for cell therapy of neurodegenerative diseases.
The results showed that the isolated hASCs were able to differentiate into both osteoblasts and adipocytes, proving their pluripotency. This finding is consistent with previous reports [36]. The accuracy of hASCs isolation was approved by flow cytometry, which showed that the purified hASCs expressed surface markers, such as CD73, CD44, and CD105 by about 90% and CD90 by about 99.6%, but they did not express CD45 and CD34 surface markers. These results were also in agreement with previous reports [37].
Neurotrophic factors are important for the growth, immigration and differentiation of neurons. In this study, we induced NTFs expression by 10–7 M of Dep, which was the highest concentration of Dep with less toxicity for hASCs.
Treated hASCs with 10–7 M of Dep showed about a three-fold higher expression of BDNF and NTF-3 genes, but they did not show any differences in NTF-4 gene expression as compared to the control group. Consistent with this result, Esmaeili et al. [31] reported higher expression of BDNF and NTF-3 genes in mice ESCs following induction by Dep. Utilizing neural stem cells, Hassanzadeh et al. [35] obtained almost similar results; the discrepancy between our results and those of Hassanzadeh et al. [35] was in NGF induction and the amount of increase in NTFs expression. In both studies, cells were treated with an identical concentration of Dep (10–7 M); however, NGF induction did not take place in our research. Furthermore, Hassanzadeh et al. [35] reported that the mRNA synthesis levels of BDNF, NGF, and NT-3 genes after Dep induction were increased more than three folds.
Using BMSCs, Ghorbanian et al. [32] also reported that Dep successfully induced BDNF, NGF, and NTF-3 genes. They used Dep at the concentration of 10–8 M. In our study, even hASCs treated with 10–8 M of Dep did not express NGF; consistent with this result, 10–8 M of Dep did not induce NGF expression in Hassanzadeh et al. [35] study. Inconsistent with Ghorbanian et al. [32] findings, we noted that despite high similarity of hASCs with BMCs, these two cell types are not identical in all features; this is in agreement with Strioga et al. [38] results. The discrepancies in findings of different studies can be attributed to cell line, species and dose differences, which can also explain the inconsistencies of our results with those of Abdanipour et al. [39]. They investigated rat adipose stem cells, while we utilized hASCs. Abdanipour et al. [39] reported higher NTF-4 gene expression and no expression of BDNF gene following Dep treatment (10–9 mM). In that study, BDNF gene expression in hASCs treated with Dep (10–7 M) increased, while treated cells with 10–8 M of Dep showed high expression of NTF-4 gene. Mizuta et al. [34] treated mouse astrocytes by 2 mM of Dep and reported higher levels of BDNF, NGF, and GDNF genes expression. Although BDNF expression was induced at all Dep concentrations in our study, inconsistent with Mizuta et al. [34] results, none of the Dep concentrations from 10–9 to 10–7 M was able to induce NGF and GDNF genes expression. Maruyama et al. [40] also pointed that Dep, unlike Rasagiline, failed to induce GDNF gene expression in treated glial cells. Dep is able to induce the expression of some of neurotrophic factor genes, such as BDNF, NTF-3, and NTF-4 in hASCs, which is inconsistent with the findings of some former studies.
In general, Dep seems an appropriate inducer factor at the concentration of 10–7 M to induce neurotrophin genes such as BDNF and NTF-3 in hASCs and differentiate them into neuron-like cells that are potentially appropriate candidates for the treatment of some neural disorders. Further studies are warranted to evaluate the effect of induced neuron-like cells in cell therapy of neurodegenerative diseases such as PD and Alzheimer’s disease.
XML Download